Loading...
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
BACKGROUND: Glioblastoma multiforme (GBM) is refractory to conventional therapies. To overcome the problem of heterogeneity, more brain tumor markers are required for prognosis and targeted therapy. We have identified and validated a promising molecular therapeutic target that is expressed by GBM: h...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2940806/ https://ncbi.nlm.nih.gov/pubmed/20809959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-468 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|